InvestorsHub Logo
Followers 3
Posts 253
Boards Moderated 0
Alias Born 08/23/2007

Re: None

Wednesday, 01/09/2019 10:29:42 PM

Wednesday, January 09, 2019 10:29:42 PM

Post# of 9709
Soligenix Announces Positive Recommendation by Independent Data Monitoring Committee on its Phase 3 Clinical Trial of SGX301 for the Treatment of Cutaneous T-cell Lymphoma

https://www.soligenix.com/news/soligenix-announces-positive-recommendation-by-independent-data-monitoring-committee-on-its-phase-3-clinical-trial-of-sgx301-for-the-treatment-of-cutaneous-t-cell-lymphoma/

Go SNGX
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNGX News